Literature DB >> 15760252

An update on endovascular therapy of the lower extremities.

Mark C Bates1, Ali F Aburahma.   

Abstract

Considerable advances have been made over the last decade in percutaneous technology for treatment of atherosclerotic diseases in the iliac, femoropopliteal, and distal tibioperoneal arteries. While treatment strategies are well defined in the iliofemoral segment, where angioplasty and stenting perform well in appropriately selected lesions, the search for a durable transcatheter therapy for femoropopliteal and distal occlusive disease continues. The spectrum of treatment alternatives to angioplasty ranges from transcatheter plaque excision to laser ablation, rotational atherectomy, cryoplasty, brachytherapy, and stenting. We review in this article the status of percutaneous endovascular techniques for the treatment of lower extremity vascular occlusive disease.

Entities:  

Mesh:

Year:  2004        PMID: 15760252     DOI: 10.1583/04-1324.1

Source DB:  PubMed          Journal:  J Endovasc Ther        ISSN: 1526-6028            Impact factor:   3.487


  4 in total

1.  Functional outcome after redo below-knee amputation.

Authors:  Chad N Stasik; Scott A Berceli; Peter R Nelson; W Anthony Lee; C Keith Ozaki
Journal:  World J Surg       Date:  2008-08       Impact factor: 3.352

2.  Self-expanding nitinol stents for treatment of infragenicular arteries following unsuccessful balloon angioplasty.

Authors:  Gunnar Tepe; Thomas Zeller; Stephan Heller; Jakub Wiskirchen; Arne Fischmann; Stephan Coerper; Bernd Balletshofer; Stefan Beckert; Claus D Claussen
Journal:  Eur Radiol       Date:  2006-12-21       Impact factor: 7.034

3.  Transmetatarsal amputation: a case series and review of the literature.

Authors:  Ryan McCallum; Mark Tagoe
Journal:  J Aging Res       Date:  2012-07-03

4.  First-in-man experience of self-expanding nitinol stents combined with drug-coated balloon in the treatment of femoropopliteal occlusive disease.

Authors:  Bibombe Patrice Mwipatayi; Kalpa Perera; Ali Daneshmand; Rhys Daniel; Jackie Wong; Shannon D Thomas; Sally A Burrows
Journal:  Vascular       Date:  2017-04-24       Impact factor: 1.285

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.